BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9537236)

  • 1. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
    McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
    Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
    Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
    Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for genetic heterogeneity in familial Wilms' tumor.
    Huff V; Amos CI; Douglass EC; Fisher R; Geiser CF; Krill CE; Li FP; Strong LC; McDonald JM
    Cancer Res; 1997 May; 57(10):1859-62. PubMed ID: 9157975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21.
    Rahman N; Arbour L; Tonin P; Renshaw J; Pelletier J; Baruchel S; Pritchard-Jones K; Stratton MR; Narod SA
    Nat Genet; 1996 Aug; 13(4):461-3. PubMed ID: 8696342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Wilms tumor.
    Ruteshouser EC; Huff V
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2.
    Rapley EA; Barfoot R; Bonaïti-Pellié C; Chompret A; Foulkes W; Perusinghe N; Reeve A; Royer-Pokora B; Schumacher V; Shelling A; Skeen J; de Tourreil S; Weirich A; Pritchard-Jones K; Stratton MR; Rahman N
    Br J Cancer; 2000 Jul; 83(2):177-83. PubMed ID: 10901367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
    Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
    Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13.
    Huff V; Compton DA; Chao LY; Strong LC; Geiser CF; Saunders GF
    Nature; 1988 Nov; 336(6197):377-8. PubMed ID: 2848200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
    Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
    Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
    Ruteshouser EC; Hendrickson BW; Colella S; Krahe R; Pinto L; Huff V
    Genes Chromosomes Cancer; 2005 Jun; 43(2):172-80. PubMed ID: 15761866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of Wilms' tumor.
    Coppes MJ; Egeler RM
    Semin Urol Oncol; 1999 Feb; 17(1):2-10. PubMed ID: 10073400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
    Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
    Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial predisposition to neuroblastoma does not map to chromosome band 1p36.
    Maris JM; Kyemba SM; Rebbeck TR; White PS; Sulman EP; Jensen SJ; Allen C; Biegel JA; Yanofsky RA; Feldman GL; Brodeur GM
    Cancer Res; 1996 Aug; 56(15):3421-5. PubMed ID: 8758905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of PPP2R1A mutations in Wilms tumor.
    Ruteshouser EC; Ashworth LK; Huff V
    Oncogene; 2001 Apr; 20(16):2050-4. PubMed ID: 11360189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide linkage in three Dutch families maps a locus for abdominal aortic aneurysms to chromosome 19q13.3.
    Van Vlijmen-Van Keulen CJ; Rauwerda JA; Pals G
    Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):29-35. PubMed ID: 15933979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of interstitial 12q deletion in association with Wilms tumor.
    Rapley EA; Hargrave D; Persinguhe N; Barfoot R; Moore I; Radford M; Stratton MR; Rahman N; Pritchard-Jones K
    Am J Med Genet; 2001 Dec; 104(3):246-9. PubMed ID: 11754052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B; Ratschek M; Harms D; Jaenig U; Leuschner I; Poremba C; Hoefler G
    Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions.
    Karnik P; Chen P; Paris M; Yeger H; Williams BR
    Oncogene; 1998 Jul; 17(2):237-40. PubMed ID: 9674708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at 7p in Wilms' tumour development.
    Powlesland RM; Charles AK; Malik KT; Reynolds PA; Pires S; Boavida M; Brown KW
    Br J Cancer; 2000 Jan; 82(2):323-9. PubMed ID: 10646884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
    Brown KW; Power F; Moore B; Charles AK; Malik KT
    Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.